Suzuki H, Aoki K, Chiba K et al (2015) Mutational landscape and clonal architecture in grade II and III gliomas. Nat Genet 47:458–468

Article  CAS  PubMed  Google Scholar 

Aoki K, Nakamura H, Suzuki H et al (2017) Prognostic relevance of genetic alterations in diffuse lower-grade gliomas. Neuro Oncol. https://doi.org/10.1093/neuonc/nox132

Article  PubMed Central  Google Scholar 

Sanai N, Polley MY, McDermott MW et al (2011) An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg 115:3–8

Article  PubMed  Google Scholar 

Brown TJ, Brennan MC, Li M et al (2016) Association of the extent of resection with survival in glioblastoma: a systematic review and meta-analysis. JAMA Oncol 2:1460–1469

Article  PubMed  PubMed Central  Google Scholar 

Motomura K, Natsume A, Watanabe R et al (2012) Immunohistochemical analysis-based proteomic subclassification of newly diagnosed glioblastomas. Cancer Sci 103:1871–1879

Article  CAS  PubMed  PubMed Central  Google Scholar 

Louis DN, Perry A, Reifenberger G et al (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803–820

Article  PubMed  Google Scholar 

Motomura K, Chalise L, Ohka F et al (2021) Impact of the extent of resection on the survival of patients with grade II and III gliomas using awake brain mapping. J Neurooncol 153:361–372

Article  PubMed  Google Scholar 

Motomura K, Natsume A, Iijima K et al (2017) Surgical benefits of combined awake craniotomy and intraoperative magnetic resonance imaging for gliomas associated with eloquent areas. J Neurosurg 127:790–797

Article  PubMed  Google Scholar 

Gerber NK, Goenka A, Turcan S et al (2014) Transcriptional diversity of long-term glioblastoma survivors. Neuro Oncol 16:1186–1195

Article  PubMed  PubMed Central  Google Scholar 

Michaelsen SR, Urup T, Olsen LR et al (2018) Molecular profiling of short-term and long-term surviving patients identifies CD34 mRNA level as prognostic for glioblastoma survival. J Neurooncol 137:533–542

Article  CAS  PubMed  Google Scholar 

Aoki K, Nakamura H, Suzuki H et al (2018) Prognostic relevance of genetic alterations in diffuse lower-grade gliomas. Neuro Oncol 20:66–77

Article  CAS  PubMed  Google Scholar 

Stichel D, Ebrahimi A, Reuss D et al (2018) Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastoma. Acta Neuropathol 136:793–803

Article  PubMed  Google Scholar 

Metellus P, Coulibaly B, Colin C et al (2010) Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis. Acta Neuropathol 120:719–729

Article  PubMed  Google Scholar 

Brat DJ, Aldape K, Colman H et al (2018) cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV.” Acta Neuropathol 136:805–810

Article  CAS  PubMed  PubMed Central  Google Scholar 

Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO Classification of tumors of the central nervous system: a summary. Neuro Oncol 23:1231–1251

Article  CAS  PubMed  PubMed Central  Google Scholar 

Berzero G, Di Stefano AL, Ronchi S et al (2021) IDH-wildtype lower-grade diffuse gliomas: the importance of histological grade and molecular assessment for prognostic stratification. Neuro Oncol 23:955–966

Article  CAS  PubMed  Google Scholar 

Wijnenga MMJ, French PJ, Dubbink HJ et al (2018) The impact of surgery in molecularly defined low-grade glioma: an integrated clinical, radiological, and molecular analysis. Neuro Oncol 20:103–112

Article  CAS  PubMed  Google Scholar 

Grogan D, Bray DP, Cosgrove M et al (2022) Clinical and radiographic characteristics of diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma: a single institution review. J Neurooncol 157:187–195

Article  PubMed  PubMed Central  Google Scholar 

Aibaidula A, Chan AK, Shi Z et al (2017) Adult IDH wild-type lower-grade gliomas should be further stratified. Neuro Oncol 19:1327–1337

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tabouret E, Nguyen AT, Dehais C et al (2016) Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohort. Acta Neuropathol 132:625–634

Article  PubMed  Google Scholar 

Cancer genome atlas research N, Brat DJ, Verhaak RG et al (2015) Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N Engl J Med 372:2481–2498

Article  Google Scholar 

Tesileanu CMS, Dirven L, Wijnenga MMJ et al (2020) Survival of diffuse astrocytic glioma, IDH1/2 wildtype, with molecular features of glioblastoma, WHO grade IV: a confirmation of the cIMPACT-now criteria. Neuro Oncol 22:515–523

Article  CAS  PubMed  Google Scholar 

Ding H, Huang Y, Li Z et al (2019) Prediction of IDH status through MRI features and enlightened reflection on the delineation of target volume in low-grade gliomas. Technol Cancer Res Treat 18:1533033819877167

Article  PubMed  PubMed Central  Google Scholar 

Park YW, Han K, Ahn SS et al (2018) Prediction of IDH1-mutation and 1p/19q-codeletion status using preoperative MR imaging phenotypes in lower grade gliomas. AJNR Am J Neuroradiol 39:37–42

Article  CAS  PubMed  PubMed Central  Google Scholar 

van Lent DI, van Baarsen KM, Snijders TJ et al (2020) Radiological differences between subtypes of WHO 2016 grade II-III gliomas: a systematic review and meta-analysis. Neurooncol Adv. https://doi.org/10.1093/noajnl/vdaa044

Article  PubMed  PubMed Central  Google Scholar 

Kibe Y, Motomura K, Ohka F et al (2023) Imaging features of localized IDH wild-type histologically diffuse astrocytomas: a single-institution case series. Sci Rep. https://doi.org/10.1038/s41598-022-25928-2

Article  PubMed  PubMed Central  Google Scholar